Class information for:
Level 1: SKIN BARRIER NETWORK HUMAN OURCES DEV TEAM BK2//LEWY BODY INCLUSION//3 4 5 TRICAFFEOYLQUINIC ACID

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
25950 267 50.7 91%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
124 3       PARKINSONS DISEASE//MOVEMENT DISORDERS//DEEP BRAIN STIMULATION 67777
332 2             PARKINSONS DISEASE//ALPHA SYNUCLEIN//PARKIN 18089
25950 1                   SKIN BARRIER NETWORK HUMAN OURCES DEV TEAM BK2//LEWY BODY INCLUSION//3 4 5 TRICAFFEOYLQUINIC ACID 267

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SKIN BARRIER NETWORK HUMAN OURCES DEV TEAM BK2 address 1039674 4% 91% 10
2 LEWY BODY INCLUSION authKW 571822 2% 100% 5
3 3 4 5 TRICAFFEOYLQUINIC ACID authKW 457458 1% 100% 4
4 APOPTOSIS RELATED PROTEIN ACTIVATION authKW 457458 1% 100% 4
5 INFLAMMATORY MEDIATOR PRODUCTION authKW 457454 2% 67% 6
6 LACTACYSTIN authKW 409005 10% 14% 26
7 MITOCHONDRIAL MEMBRANE PERMEABILITY CHANGE authKW 365964 1% 80% 4
8 QGR authKW 343093 1% 100% 3
9 ROTUNDARPENE authKW 343093 1% 100% 3
10 MITOCHONDRIAL MEMBRANE PERMEABILITY authKW 337498 4% 27% 11

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Neurosciences 2124 52% 0% 138
2 Biochemistry & Molecular Biology 281 30% 0% 79
3 Pharmacology & Pharmacy 230 19% 0% 51
4 Cell Biology 82 11% 0% 29
5 Clinical Neurology 72 9% 0% 23
6 Toxicology 41 4% 0% 12
7 Behavioral Sciences 17 2% 0% 6
8 Medicine, Research & Experimental 9 3% 0% 9
9 Anatomy & Morphology 5 1% 0% 2
10 Geriatrics & Gerontology 2 1% 0% 2

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SKIN BARRIER NETWORK HUMAN OURCES DEV TEAM BK2 1039674 4% 91% 10
2 ALZHEIMER DIS ASSESSMENT UNIT 114364 0% 100% 1
3 AREA TECNOL FANNACEUTUNIDAD NEUROPSICOFARMACOL T 114364 0% 100% 1
4 BIOCHEM PL 114364 0% 100% 1
5 BK21PLUS SKIN BARRIER NETWORK HUMAN OURCES DEV 114364 0% 100% 1
6 DSVMIRCENURA CEACNRS 2210 114364 0% 100% 1
7 EA1636 114364 0% 100% 1
8 GRP INVEST SISTEMAS INTELIGENTES MINERIA DATOS 114364 0% 100% 1
9 MOVEMENT DIS R211 114364 0% 100% 1
10 SKIN BARRIER NETWORK HUMAN OURCES DEV BK21PLUS 114364 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF NEUROCHEMISTRY 3701 10% 0% 26
2 NEUROCHEMISTRY INTERNATIONAL 1365 3% 0% 8
3 NEUROCHEMICAL RESEARCH 1261 3% 0% 9
4 ANNALS OF NEUROLOGY 1179 3% 0% 9
5 BANGLADESH JOURNAL OF PHARMACOLOGY 766 1% 0% 2
6 CELLULAR AND MOLECULAR NEUROBIOLOGY 736 1% 0% 4
7 JOURNAL DE TOXICOLOGIE CLINIQUE ET EXPERIMENTALE 722 0% 1% 1
8 JOURNAL OF NEURAL TRANSMISSION 694 2% 0% 5
9 BMC NEUROSCIENCE 616 1% 0% 3
10 PEZCOLLER FOUNDATION SYMPOSIA 505 1% 0% 3

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 LEWY BODY INCLUSION 571822 2% 100% 5 Search LEWY+BODY+INCLUSION Search LEWY+BODY+INCLUSION
2 3 4 5 TRICAFFEOYLQUINIC ACID 457458 1% 100% 4 Search 3+4+5+TRICAFFEOYLQUINIC+ACID Search 3+4+5+TRICAFFEOYLQUINIC+ACID
3 APOPTOSIS RELATED PROTEIN ACTIVATION 457458 1% 100% 4 Search APOPTOSIS+RELATED+PROTEIN+ACTIVATION Search APOPTOSIS+RELATED+PROTEIN+ACTIVATION
4 INFLAMMATORY MEDIATOR PRODUCTION 457454 2% 67% 6 Search INFLAMMATORY+MEDIATOR+PRODUCTION Search INFLAMMATORY+MEDIATOR+PRODUCTION
5 LACTACYSTIN 409005 10% 14% 26 Search LACTACYSTIN Search LACTACYSTIN
6 MITOCHONDRIAL MEMBRANE PERMEABILITY CHANGE 365964 1% 80% 4 Search MITOCHONDRIAL+MEMBRANE+PERMEABILITY+CHANGE Search MITOCHONDRIAL+MEMBRANE+PERMEABILITY+CHANGE
7 QGR 343093 1% 100% 3 Search QGR Search QGR
8 ROTUNDARPENE 343093 1% 100% 3 Search ROTUNDARPENE Search ROTUNDARPENE
9 MITOCHONDRIAL MEMBRANE PERMEABILITY 337498 4% 27% 11 Search MITOCHONDRIAL+MEMBRANE+PERMEABILITY Search MITOCHONDRIAL+MEMBRANE+PERMEABILITY
10 APOPTOSIS RELATECL PROTEINS 228729 1% 100% 2 Search APOPTOSIS+RELATECL+PROTEINS Search APOPTOSIS+RELATECL+PROTEINS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 MACKEY, S , JING, Y , FLORES, J , DINELLE, K , DOUDET, DJ , (2013) DIRECT INTRANIGRAL ADMINISTRATION OF AN UBIQUITIN PROTEASOME SYSTEM INHIBITOR IN RAT: BEHAVIOR, POSITRON EMISSION TOMOGRAPHY, IMMUNOHISTOCHEMISTRY.EXPERIMENTAL NEUROLOGY. VOL. 247. ISSUE . P. 19-24 23 56% 13
2 NAM, YJ , LEE, DH , KIM, YJ , SHIN, YK , SOHN, DS , LEE, MS , LEE, CS , (2014) 3,4,5-TRICAFFEOYLQUINIC ACID ATTENUATES PROTEASOME INHIBITION-MEDIATED PROGRAMMED CELL DEATH IN DIFFERENTIATED PC12 CELLS.NEUROCHEMICAL RESEARCH. VOL. 39. ISSUE 8. P. 1416 -1425 22 50% 0
3 ZHOU, HY , TAN, YY , WANG, ZQ , WANG, G , LU, GQ , CHEN, SD , (2010) PROTEASOME INHIBITOR LACTACYSTIN INDUCES CHOLINERGIC DEGENERATION.CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. VOL. 37. ISSUE 2. P. 229-234 21 57% 2
4 BUKHATWA, S , ZENG, BY , ROSE, S , JENNER, P , (2010) THE EFFECTS OF DOSE AND ROUTE OF ADMINISTRATION OF PSI ON BEHAVIOURAL AND BIOCHEMICAL INDICES OF NEURONAL DEGENERATION IN THE RAT BRAIN.BRAIN RESEARCH. VOL. 1354. ISSUE . P. 236-242 14 78% 2
5 SHIN, M , JAN, C , JACQUARD, C , JARRAYA, B , CALLEBERT, J , LAUNAY, JM , HANTRAYE, P , REMY, P , PALFI, S , BROUILLET, E , (2011) CHRONIC SYSTEMIC TREATMENT WITH A HIGH-DOSE PROTEASOME INHIBITOR IN MICE PRODUCES AKINESIA UNRELATED TO NIGROSTRIATAL DEGENERATION.NEUROBIOLOGY OF AGING. VOL. 32. ISSUE 11. P. 2100-2102 10 100% 4
6 KONIECZNY, J , JANTAS, D , LENDA, T , DOMIN, H , CZARNECKA, A , KUTER, K , SMIALOWSKA, M , LASON, W , LORENC-KOCI, E , (2014) LACK OF NEUROPROTECTIVE EFFECT OF CELASTROL UNDER CONDITIONS OF PROTEASOME INHIBITION BY LACTACYSTIN IN IN VITRO AND IN VIVO STUDIES: IMPLICATIONS FOR PARKINSON'S DISEASE.NEUROTOXICITY RESEARCH. VOL. 26. ISSUE 3. P. 255 -273 25 33% 3
7 KORDOWER, JH , KANAAN, NM , CHU, Y , BABU, RS , STANSELL, J , TERPSTRA, BT , SORTWELL, CE , STEECE-COLLIER, K , COLLIER, TJ , (2006) FAILURE OF PROTEASOME INHIBITOR ADMINISTRATION TO PROVIDE A MODEL OF PARKINSON'S DISEASE IN RATS AND MONKEYS.ANNALS OF NEUROLOGY. VOL. 60. ISSUE 2. P. 264-268 14 64% 84
8 JUNG, EB , LEE, CS , (2014) BAICALEIN ATTENUATES PROTEASOME INHIBITION-INDUCED APOPTOSIS BY SUPPRESSING THE ACTIVATION OF THE MITOCHONDRIAL PATHWAY AND THE CASPASE-8-AND BID-DEPENDENT PATHWAYS.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 730. ISSUE . P. 116-124 19 40% 7
9 HIRST, SJ , FERGER, B , (2008) SYSTEMIC PROTEASOMAL INHIBITOR EXPOSURE ENHANCES DOPAMINE TURNOVER AND DECREASES DOPAMINE LEVELS BUT DOES NOT AFFECT MPTP-INDUCED STRIATAL DOPAMINE DEPLETION IN MICE.SYNAPSE. VOL. 62. ISSUE 2. P. 85-90 13 72% 4
10 MCNAUGHT, KS , OLANOW, CW , (2006) PROTEASOME INHIBITOR-INDUCED MODEL OF PARKINSON'S DISEASE (RETRACTED ARTICLE. SEE VOL 65, PG 485, 2009).ANNALS OF NEUROLOGY. VOL. 60. ISSUE 2. P. 243 -247 13 65% 54

Classes with closest relation at Level 1


Rank Class id link
1 24398 ROTENONE//AAV ALPHA SYNUCLEIN//PYRIMIDOTRIAZINEDIONE DERIVATIVES
2 18772 UCH L1//UBIQUITIN CARBOXY TERMINAL HYDROLASE L1//DEGENERAT NEUROL DIS
3 477 ALPHA SYNUCLEIN//SYNUCLEIN//LEWY BODY
4 4709 PARKIN//PINK1//PARK2
5 29114 PRAMIPEXOLE//PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE//TALIPEXOLE
6 7381 NEUROMELANIN//AMINOCHROME//DOPAMINE QUINONE
7 29898 3 4 DIHYDROXYPHENYLACETALDEHYDE//3 4 DIHYDROXYPHENYLGLYCOLALDEHYDE//DOPAL
8 5140 PROTEASOME INHIBITOR//BORTEZOMIB//PROTEASOME
9 36064 DERMO EPIDERMAL SEPARATION//INNATE IMMUNITY OF THE SKIN//PERMAFROST MICROORGANISMS
10 9023 PROTEIN OXIDATION//METAL CATALYZED OXIDATION//CLIN PHYS MED

Go to start page